| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, 10% Owner | 10% Owner | Director
5 companies
Kreis Leslie W. is a Director, 10% Owner at INAB with holdings across 5 companies. Recent SEC Form 4 filings include 3 buys and 58 sells.
Estimated insider holdings value: $2.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 27, 2025 | ACTU Actuate Therapeutics, Inc. | Director, 10% Owner | Buy | 71,428 | $7.00 | $499,996.00 | +57.1% | +11.6% | - | |
| Jun 13, 2025 | LTRN Lantern Pharma Inc. | 10% Owner | Sell | 40,000 | $3.09 | $123,600.00 | -3.7% | +28.9% | - | |
| Jun 12, 2025 | LTRN Lantern Pharma Inc. | 10% Owner | Sell | 61,613 | $3.38 | $208,271.26 | -1.8% | +22.6% | - | |
| May 29, 2025 | LTRN Lantern Pharma Inc. | 10% Owner | Sell | 56,237 | $2.99 | $168,418.85 | -1.6% | +29.4% | - | |
| Aug 14, 2024 | ACTU Actuate Therapeutics, Inc. | 10% Owner | Buy | 500,000 | $8.00 | $4,000,000.00 | +56.5% | -1.4% | -10.2% | |
| Aug 14, 2024 | ACTU Actuate Therapeutics, Inc. | 10% Owner | Sell | 24,999 | $9.00 | $224,991.00 | -1.7% | -1.4% | -10.2% | |
| May 24, 2024 | LTRN Lantern Pharma Inc. | 10% Owner | Sell | 30,000 | $6.30 | $189,100.00 | -2.3% | -32.7% | -47.5% | |
| Feb 29, 2024 | LTRN Lantern Pharma Inc. | 10% Owner | Sell | 144,000 | $4.70 | $676,294.06 | -6.5% | +24.9% | -17.9% | |
| Jan 17, 2024 | LTRN Lantern Pharma Inc. | 10% Owner | Sell | 58,889 | $4.20 | $247,333.80 | -6.9% | +60.9% | -3.5% | |
| Nov 29, 2023 | LTRN Lantern Pharma Inc. | 10% Owner | Sell | 145,348 | $3.44 | $499,997.12 | -19.8% | +15.1% | -17.9% |